Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US FDA’s Biologics Center Faces Exciting 2019 After Quiet Year For Novel Approvals

Jan 21 2019

• By Bridget Silverman

Pink Sheet prespectives 2018 to 2019

Related Content

J.P. Morgan 2019: Industry Throws A Bonanza, With An Elephant In The Room

Jan 10 2019

Gene Therapies: Accelerated Approval Open For Some, But Not All, Neurodegenerative Disease Treatments

Jan 08 2019

Orphan Drugs Compose Majority Of Novel US Approvals For First Time Ever In 2018

Jan 03 2019

Gene Therapy’s Next Big Challenge: Manufacturing

Jan 21 2019

Keeping Track: Xarelto Earns CV Risk Reduction Claim In Quiet Week; Spotlight On Formal Dispute Resolution

Oct 14 2018

Keeping Track: J&J Esketamine, Sanofi Caplacizumab Lead Off September Submissions; US FDA Says No To Nucala

Sep 10 2018

Keeping Track: Dueling 'Breakthroughs' For Peanut Allergy

Jun 22 2015

Anticancers, Orphans & The First CAR-Ts: New EU Drug Approvals In 2018

Jan 09 2019

DBV Technologies Misses With Viaskin Peanut Allergy Patch

Oct 23 2017

Brakes On Sanofi’s Dengvaxia Prospects Amid WHO-SAGE Screening Advice?

Apr 25 2018

The Case For CAR-T Grows As Responses Hold Up Longer Term

Dec 21 2018

Will Sanofi’s Dengvaxia Woes Spiral Beyond The Philippines?

Feb 06 2018

Bavarian Nordic CEO Says Likely To Sell Imvamune Priority Review Voucher

Feb 13 2018

Related Companies

Portola Pharmaceuticals, Inc.

Novartis AG

Aimmune Therapeutics, Inc.

DBV Technologies

Sanofi

Bayer AG

Octapharma AG

Kite Pharma, Inc.

Spark Therapeutics, Inc.

Liminal BioSciences Inc.

ADMA Biologics, Inc.

Johnson & Johnson

Bristol Myers Squibb Company

Pfizer Inc.

Bavarian Nordic A/S

Emergent BioSolutions, Inc.

SIGA Technologies, Inc

Takeda Pharmaceutical Co. Ltd.

Additional Topics

United States Vaccines Biologics Drug Review Drug Approval Standards Regulation BioPharmaceutical

More from Vaccines

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window